This MAb recognizes an intermediate filament protein of 46kDa, identified as cytokeratin 20 (KRT20). KRT20 is abundantly expressed in goblet cells and enterocytes of the gastrointestinal tract. It is a useful marker of pancreatic and colorectal cancer. KRT20 is expressed under normal, hyperplastic and neoplastic conditions.It has been detected in adenocarcinomas of the colon, stomachand biliary tract. Breast carcinomas are generally non-reactive.
This MAb recognizes an intermediate filament protein of 46kDa, identified as cytokeratin 20 (KRT20). KRT20 is abundantly expressed in goblet cells and enterocytes of the gastrointestinal tract. It is a useful marker of pancreatic and colorectal cancer. KRT20 is expressed under normal, hyperplastic and neoplastic conditions.It has been detected in adenocarcinomas of the colon, stomachand biliary tract. Breast carcinomas are generally non-reactive.
Shipping & Handling
Shipped In
Blue Ice
Safety & Storage
Storage Temperature
Store the recombinant CK20 antibody at 2-8oC (with azide) or aliquot and store at -20oC or colder (without azide).
Safety Statement
For research use only.
Regulatory & Compliance
Specifications
CLASS
Primary Antibody
APPLICATION
IHC-P, WB
*USAGE / SAFETY STATEMENT
For research use only.
PURITY
Protein A affinity chromatography
HOST SPECIES
Rabbit
ISOTYPE
Rabbit IgG
REACTIVITY SPECIES
Human
CLONALITY
Clonality.RECOMBINANT
CONJUGATION/TAG
Unconjugated
APPLICATION DILUTIONS
Western blot: 1-2ug/ml,Immunohistochemistry (FFPE): 1-2ug/ml
APPLICATION NOTES
Optimal dilution of the antibody should be determined by the researcher.
We’re currently in BETA - Interested in joining? Let us know and we’ll get you set up with early access.